Isolated limb perfusion in primary and recurrent melanoma: Indications and results

Keyphrases

• Isolated Limb Perfusion 100%
• Recurrent Melanoma 100%
• Primary Melanoma 100%
• Melphalan 85%
• In-transit Metastasis 57%
• Complete Remission 42%
• Melanoma 42%
• High Risk 28%
• Interferon-γ 28%
• Cancer Treatment 14%
• Randomized Phase II Trial 14%
• Prospective Randomized Trial 14%
• Tumor Necrosis Factor-α 14%
• Phase II Study 14%
• North America 14%
• Response Rate 14%
• World Health Organization 14%
• European Organizations 14%
• Disease-free Interval 14%
• Remission Rate 14%
• Perfusion 14%
• Lymph Node Dissection 14%
• Locoregional Therapy 14%
• Advanced Melanoma 14%
• Regional Response 14%
• Breslow 14%

Medicine and Dentistry

• Limb Perfusion 100%
• Melanoma 100%
• Melphalan 85%
• In-Transit Metastasis 57%
• Limb 42%
• Spontaneous Remission 28%
• Gamma Interferon 28%
• Disease 14%
• Tumor Necrosis Factor 14%
• Cancer Treatment 14%
• Retroperitoneal Lymph Node Dissection 14%